AI Science Tracker
EN

Generative models nominate unconfirmed MDM2-binding candidates

University of Science and Technology of China; University of Nigeria; University of Texas Southwestern Medical Center · 26 Apr 2024 · medicine

Discovery

Generative models nominate unconfirmed MDM2-binding candidates

Source check: Source checked. Not independent scientific confirmation.

Finding: RFdiffusion, ProteinMPNN and AlphaFold supported two source-labeled candidate designs for the oncology-related MDM2–p53 interaction. Conventional enhanced-sampling simulations favored one candidate over the other and the reference. These are unconfirmed computational candidates, without measured binding affinity or therapeutic evidence.

Technology: RFdiffusion; ProteinMPNN; AlphaFold

Family AlphaFold: profile · models page

Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.

AI contribution
The primary Conclusion attributes backbone generation to RFdiffusion, candidate sequence modeling to ProteinMPNN and structure prediction/refinement to AlphaFold. Learned design is separate from the conventional simulation comparison.
Test and result
The source reports two computational candidates and an enhanced-sampling comparison favoring its Pep1 candidate relative to Pep2 and the reference. Validation3 refers only to the reported explicit computational comparison within the discovery study, not experimental binding confirmation.
Limitation / still unknown
No empirical affinity, target novelty, clinical benefit or independent replication is established. Operational sequences/design recipes and full simulation implementation details were not inspected or retained. Molecular simulations do not establish actual inhibitor activity or therapeutic utility; the represented result remains conditional on the source’s computational models.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://abeebyekeen.com/research/Files/2024_Investigation%20of%20the%20MDM2-binding%20potential%20of%20de%20novo%20designed%20peptides%20using%20enhanced%20sampling%20simulations.pdf · https://doi.org/10.1016/j.ijbiomac.2024.131840

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: linked separately.

Review date: 21 Nov 2026. Review scope: Exact original publisher front, primary abstract and nonprocedural Conclusion in author deposit; full operational sequence/design Methods not read or retained.

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 1/5 · Validation 3/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.

Related catalog entries

Links use documented relationships where available, plus shared catalog context. A shared topic or model family does not establish a scientific dependency.